查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2085836

胰島素幫浦市場：2026-2032年全球市場預測（依產品類型、給藥方式、胰島素類型、應用及通路分類）

Insulin Pumps Market by Product Type, Delivery Mode, Insulin Type, Application, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，胰島素幫浦市場規模將達到 105.9 億美元，複合年成長率為 8.77%。

主要市場統計數據
基準年 2025 58.8億美元
預計年份：2026年 63.8億美元
預測年份 2032 105.9億美元
複合年成長率 (%) 8.77%

隨著糖尿病盛行率上升、持續血糖監測（CGM）普及率加快以及自動胰島素輸注成為強化糖尿病管理的核心標準，胰島素幫浦市場正在不斷擴張。根據國際糖尿病聯盟（IDF）估計，全球數億成年人患有糖尿病；美國疾病管制與預防中心（CDC）報告稱，僅美國就有超過3800萬人患有糖尿病。日益加重的臨床負擔推動了對可靠的連網胰島素輸注設備的需求，這些設備能夠延長血糖值維持在目標範圍內的時間，控制血糖值波動，並減輕患者日常自我管理糖尿病的負擔。

現代胰島素幫浦系統在演算法效能、互通性、適配性、儲液器和輸注裝置設計、資料整合、網路安全以及保險覆蓋範圍等方面展開競爭。在內分泌基礎設施完善、動態血糖監測普及率高且保險公司支持力度強的地區，胰島素幫浦系統的成長最為顯著，但隨著都市化、診斷率的提高以及對數位醫療投資的增加，新興市場的重要性也日益凸顯。

胰島素幫浦產業的變革性變化

胰島素幫浦市場正從獨立的輸注設備轉向整合式糖尿病技術生態系統。管式幫浦、貼片幫浦、動態血糖監測儀 (CGM)、智慧胰島素筆、行動應用程式和基於雲端的醫療專業人員控制面板正在融合，形成互聯互通的醫療平台。混合式閉合迴路和自動化胰島素輸注系統將基於感測器的血糖數據與基於演算法的基礎胰島素劑量調整和校正支援相結合，正在改變消費者的預期。

人工智慧（AI）的累積影響

人工智慧 (AI) 透過改善血糖值預測、胰島素輸注輔助、警報優先順序設定和行為模式識別，對胰島素幫浦產生了累積的影響。 AI 演算法分析 CGM 趨勢、體內胰島素水平、碳水化合物攝取量、活動模式和先前反應，從而支持更個人化的治療。在閉合迴路系統中，這些功能有助於降低低血糖風險，並延長血糖在目標範圍內的時間，尤其是在夜間和白天睡眠模式波動期間。

對關鍵區域的洞察

北美仍然是胰島素幫浦市場最成熟的地區，其中美國和加拿大主導。在這些國家，持續血糖監測儀（CGM）的普及、專科醫生的便捷就診、FDA批准的自動胰島素輸注系統以及公共和私人保險的報銷，都推動了該產品的推廣應用。歐洲市場也穩定發展，德國、法國、英國、義大利和西班牙的胰島素幫浦普及率較高。然而，採購法規、國家報銷政策以及醫療設備法規（MDR）的合規性，都會影響產品的上市計畫和定價策略。

關鍵群體特定見解

東協正成為胰島素幫浦的新興成長中心，新加坡、馬來西亞、泰國、印尼、越南和菲律賓都在加大對糖尿病照護系統和數位醫療的投入。儘管由於報銷體系和內分泌診療服務可近性方面的巨大差異，各地區的胰島素幫浦普及率存在顯著差異，但都市區私立醫院和兒童1型糖尿病計畫對胰島素幫浦治療和動態血糖監測（CGM）整合解決方案的初步需求已經顯現。

主要國家的概況

美國憑藉其獲得FDA批准的自動胰島素輸注系統、廣泛使用的持續血糖監測儀（CGM）以及龐大的糖尿病患者群體，在胰島素幫浦市場佔據領先地位。加拿大的優勢在於其省級胰島素幫浦推廣計畫以及臨床機構對胰島素幫浦的高度認知。同時，墨西哥的需求主要集中在私立醫療機構和都市區專科醫療中心。巴西擁有拉丁美洲最大的市場潛力，但報銷機制的差異和定價問題阻礙了胰島素幫浦的普及。

為行業領導者提供的實用建議

產業領導者應優先考慮經臨床檢驗的自動化胰島素輸注系統、增強的動態血糖監測（CGM）互通性以及以患者為中心的、可減輕設備負擔的胰島素幫浦設計。證據生成應著重於目標血糖範圍內的時間、降低低血糖發生率、提高生活品質（QOL）、改善兒童治療效果、妊娠期應用案例以及符合臨床指南的需要胰島素治療的2型糖尿病患者群體。

調查方法

本執行摘要根據公共衛生機構、監管機構、臨床指南、同行評審文獻、報銷政策以及糖尿病技術採納指標的二手研究資料。主要資訊來源包括國際糖尿病聯盟（IDF）、世界衛生組織（WHO）、美國疾病管制與預防中心（CDC）、美國食品藥物管理局（FDA）、歐盟委員會的醫療設備相關資料、英國國家衛生與臨床最佳化研究所（NICE）以及各國糖尿病協會。

結論

胰島素幫浦市場正進入一個新階段，其特點是胰島素自動輸注、人工智慧驅動的個人化治療、與持續血糖監測（CGM）的整合以及基於實證醫學的報銷機制。全球糖尿病負擔沉重，以及臨床上對改善血糖控制和減輕患者負擔的需求，共同推動了市場需求的成長。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 胰島素幫浦市場：依產品類型分類

  • 胰島素幫浦（管式）
  • 無管胰島素泵
  • 小型泵浦
  • 傳統胰島素泵

第8章 胰島素幫浦市場：依輸送方式分類

  • 持續皮下胰島素輸注
  • 混合閉合迴路系統
  • 自動胰島素注射

第9章：胰島素幫浦市場：依胰島素類型分類

  • 快速起效
  • 短期型

第10章：胰島素幫浦市場：依應用領域分類

  • 1型糖尿病
  • 2型糖尿病

第11章 胰島素幫浦市場：依通路分類

  • 醫院藥房
  • 網路藥房
  • 零售藥房

第12章 胰島素幫浦市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章 胰島素幫浦市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 胰島素幫浦市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Beta Bionics, Inc.
  • Cellnovo Group SA
  • Dana Diabecare Co., Ltd
  • Debiotech SA
  • Dexcom, Inc.
  • EOFlow Co., Ltd.
  • F. Hoffmann-La Roche Ltd.
  • HMicro Inc.
  • Insulet Corporation
  • Jiangsu Delfu Medical Device Co., Ltd.
  • Medingo Ltd.
  • Medtronic plc
  • Medtrum Technologies Inc.
  • MicroPort Lifesciences Co., Ltd.
  • MicroTech Medical（Hangzhou）Co., Ltd.
  • NIPRO Corporation
  • PharmaSens AG
  • Phray Technology Co., Ltd.
  • SFC Fluidics, Inc.
  • SOOIL Development Co., Ltd.
  • Tandem Diabetes Care, Inc.
  • Terumo Corporation.
  • ViCentra BV
  • Ypsomed Holding AG
  • Zhuhai Fornia Medical Device Co., Ltd.
Product Code: MRR-43127F7279B9

The Insulin Pumps Market is projected to grow by USD 10.59 billion at a CAGR of 8.77% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 5.88 billion
Estimated Year [2026] USD 6.38 billion
Forecast Year [2032] USD 10.59 billion
CAGR (%) 8.77%

The insulin pumps market is expanding as diabetes prevalence rises, continuous glucose monitoring (CGM) adoption accelerates, and automated insulin delivery becomes a central standard in intensive diabetes management. The International Diabetes Federation estimates that hundreds of millions of adults live with diabetes globally, while the CDC reports more than 38 million people with diabetes in the United States alone. This clinical burden is increasing demand for reliable, connected insulin delivery devices that improve time in range, reduce glycemic variability, and lessen the daily workload of diabetes self-management.

Modern insulin pump systems now compete on algorithm performance, interoperability, wearability, reservoir and infusion-set design, data integration, cybersecurity, and reimbursement accessibility. Growth is strongest where endocrinology infrastructure, CGM coverage, and payer support align, while emerging markets are becoming increasingly important as urbanization, diagnosis rates, and digital health investment rise.

Transformative Shifts in the Insulin Pump Landscape

The insulin pumps landscape is shifting from stand-alone infusion devices toward integrated diabetes technology ecosystems. Tubed pumps, patch pumps, CGMs, smart pens, mobile apps, and cloud-based clinician dashboards are converging into connected care platforms. Hybrid closed-loop and automated insulin delivery systems have changed buyer expectations by combining sensor glucose data with algorithm-driven basal adjustments and correction support.

Regulation and reimbursement are also reshaping competition. The U.S. FDA's interoperable pump and integrated CGM pathways, Europe's Medical Device Regulation, and national health technology assessments are raising evidence requirements while encouraging safer device connectivity. At the same time, patient preference is moving toward smaller, discreet, waterproof, and smartphone-enabled products that support flexible lifestyles without compromising clinical reliability.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is having a cumulative impact on insulin pumps by improving glucose prediction, insulin dosing support, alarm prioritization, and behavioral pattern recognition. AI-enabled algorithms can analyze CGM trends, insulin-on-board, carbohydrate inputs, activity patterns, and historical responses to support more personalized therapy. In closed-loop systems, these capabilities help reduce hypoglycemia risk and increase time in range, especially overnight and during variable daily routines.

The opportunity comes with governance requirements. AI-driven insulin delivery must meet rigorous standards for clinical validation, explainability, human override, post-market surveillance, and cybersecurity. Industry leaders that pair machine learning innovation with transparent evidence, real-world performance monitoring, and clinician trust will be better positioned as regulators and payers scrutinize digital therapeutics and connected medical devices more closely.

Key Regional Insights

North America remains the most mature insulin pumps market, led by the United States and Canada, where CGM penetration, specialist access, FDA-cleared automated insulin delivery systems, and private and public reimbursement support adoption. Europe is similarly advanced, with strong uptake across Germany, France, the United Kingdom, Italy, and Spain, although procurement rules, national reimbursement decisions, and MDR compliance shape launch timelines and pricing strategies.

Asia-Pacific is the fastest-evolving opportunity, supported by large diabetes populations in China, India, Japan, South Korea, and Australia. Japan and Australia show strong technology readiness, while China and India present long-term volume potential as diagnosis, affordability, and diabetes care infrastructure improve. Latin America, led by Brazil and Mexico, is growing through private healthcare channels and expanding specialist awareness, though coverage gaps remain a constraint.

The Middle East is gaining momentum through premium healthcare investment, high diabetes prevalence, and public-sector modernization in Gulf countries. Africa remains underpenetrated due to affordability, insulin access, trained clinician availability, and supply-chain constraints, but urban private care, telehealth, and nonprofit diabetes programs are creating selective entry points for connected insulin delivery.

Key Group Insights

ASEAN is an emerging growth cluster for insulin pumps as Singapore, Malaysia, Thailand, Indonesia, Vietnam, and the Philippines invest in diabetes care capacity and digital health. Adoption is uneven because reimbursement and endocrinology access vary widely, but urban private hospitals and pediatric type 1 diabetes programs are creating early demand for pump therapy and CGM-linked solutions.

The GCC is a high-potential market due to elevated diabetes prevalence, strong healthcare spending, and government-led modernization in Saudi Arabia, the United Arab Emirates, Qatar, Kuwait, Bahrain, and Oman. The European Union provides a structured but demanding environment where CE marking, MDR compliance, health technology assessment, and country-level reimbursement determine commercial success.

BRICS countries offer scale, led by China, India, and Brazil, but require pricing flexibility, local partnerships, and education-led market development. G7 countries remain innovation and reimbursement anchors, with the United States, Japan, Germany, the United Kingdom, France, Italy, and Canada shaping clinical evidence expectations. NATO markets overlap heavily with North America and Europe, where defense-sector healthcare systems and advanced public procurement can support access for eligible populations.

Key Country Insights

The United States is the leading insulin pumps market, supported by FDA-cleared automated insulin delivery systems, widespread CGM adoption, and a large population living with diabetes. Canada benefits from provincial pump programs and strong clinical awareness, while Mexico's demand is concentrated in private care and urban specialist centers. Brazil is Latin America's largest opportunity, although reimbursement fragmentation and affordability influence uptake.

In Europe, the United Kingdom benefits from NICE guidance supporting diabetes technology where clinically appropriate, while Germany and France have established reimbursement pathways and strong specialist networks. Italy and Spain show steady adoption through regional health systems, and Russia remains more complex due to procurement, regulatory, and access barriers.

China has substantial long-term potential because of its large diabetes population and expanding medtech ecosystem, while India is driven by rising diagnosis rates, private healthcare growth, and affordability challenges. Japan, Australia, and South Korea are technologically advanced markets with strong acceptance of connected devices, making them important launch and evidence-generation countries in Asia-Pacific.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated automated insulin delivery, stronger CGM interoperability, and patient-centered pump design that reduces device burden. Evidence generation should focus on time in range, hypoglycemia reduction, quality of life, pediatric outcomes, pregnancy use cases, and insulin-requiring type 2 diabetes populations where supported by clinical guidelines.

Companies should expand access through payer partnerships, value-based evidence, subscription models, and localized education for clinicians and diabetes educators. In emerging markets, tiered pricing, robust training, local distribution, and reliable consumables supply are essential. Across all regions, cybersecurity, data privacy, post-market monitoring, and transparent AI governance should be treated as core competitive capabilities rather than compliance afterthoughts.

Research Methodology

This executive summary is based on secondary research from public health agencies, regulatory bodies, clinical guidelines, peer-reviewed literature, reimbursement policies, and diabetes technology adoption indicators. Key reference sources include the International Diabetes Federation, World Health Organization, CDC, FDA, European Commission medical device resources, NICE, and national diabetes associations.

The analysis triangulates epidemiology, device innovation, reimbursement maturity, regional access conditions, and competitive dynamics to identify market direction. Insights are structured to support strategic planning and executive decision-making while avoiding unverified market-size claims or unsupported growth assumptions.

Conclusion

The insulin pumps market is entering a new phase defined by automated insulin delivery, AI-assisted personalization, CGM integration, and evidence-based reimbursement. Demand is supported by the global diabetes burden and by the clinical need to improve glycemic outcomes while reducing patient workload.

Companies that combine validated algorithms, intuitive design, interoperability, affordability, and secure data infrastructure will be best positioned to capture growth. The strongest opportunities will come from aligning innovation with payer value, clinician confidence, and equitable access across mature and emerging healthcare systems.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Insulin Pumps Market, by Product Type

  • 7.1. Tubed Insulin Pumps
  • 7.2. Tubeless Insulin Pumps
  • 7.3. Miniature Pumps
  • 7.4. Conventional Insulin Pumps

8. Insulin Pumps Market, by Delivery Mode

  • 8.1. Continuous Subcutaneous Insulin Infusion
  • 8.2. Hybrid Closed-Loop Systems
  • 8.3. Automated Insulin Delivery

9. Insulin Pumps Market, by Insulin Type

  • 9.1. Rapid Acting
  • 9.2. Short Acting

10. Insulin Pumps Market, by Application

  • 10.1. Type 1 Diabetes
  • 10.2. Type 2 Diabetes

11. Insulin Pumps Market, by Distribution Channel

  • 11.1. Hospital Pharmacy
  • 11.2. Online Pharmacy
  • 11.3. Retail Pharmacy

12. Insulin Pumps Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Insulin Pumps Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Insulin Pumps Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Concentration Analysis, 2025
    • 15.1.1. Concentration Ratio (CR)
    • 15.1.2. Herfindahl Hirschman Index (HHI)
  • 15.2. Recent Developments & Impact Analysis, 2025
  • 15.3. Product Portfolio Analysis, 2025
  • 15.4. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Beta Bionics, Inc.
  • 16.2. Cellnovo Group SA
  • 16.3. Dana Diabecare Co., Ltd
  • 16.4. Debiotech S.A.
  • 16.5. Dexcom, Inc.
  • 16.6. EOFlow Co., Ltd.
  • 16.7. F. Hoffmann-La Roche Ltd.
  • 16.8. HMicro Inc.
  • 16.9. Insulet Corporation
  • 16.10. Jiangsu Delfu Medical Device Co., Ltd.
  • 16.11. Medingo Ltd.
  • 16.12. Medtronic plc
  • 16.13. Medtrum Technologies Inc.
  • 16.14. MicroPort Lifesciences Co., Ltd.
  • 16.15. MicroTech Medical (Hangzhou) Co., Ltd.
  • 16.16. NIPRO Corporation
  • 16.17. PharmaSens AG
  • 16.18. Phray Technology Co., Ltd.
  • 16.19. SFC Fluidics, Inc.
  • 16.20. SOOIL Development Co., Ltd.
  • 16.21. Tandem Diabetes Care, Inc.
  • 16.22. Terumo Corporation.
  • 16.23. ViCentra B.V.
  • 16.24. Ypsomed Holding AG
  • 16.25. Zhuhai Fornia Medical Device Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL INSULIN PUMPS MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL INSULIN PUMPS MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL INSULIN PUMPS MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL INSULIN PUMPS MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL INSULIN PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL INSULIN PUMPS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL INSULIN PUMPS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL INSULIN PUMPS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL INSULIN PUMPS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL INSULIN PUMPS MARKET SIZE, BY DELIVERY MODE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL INSULIN PUMPS MARKET SIZE, BY DELIVERY MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL INSULIN PUMPS MARKET SIZE, BY INSULIN TYPE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL INSULIN PUMPS MARKET SIZE, BY INSULIN TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL INSULIN PUMPS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL INSULIN PUMPS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL INSULIN PUMPS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL INSULIN PUMPS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL INSULIN PUMPS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL INSULIN PUMPS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL INSULIN PUMPS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL INSULIN PUMPS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL INSULIN PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL INSULIN PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL TUBED INSULIN PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL TUBED INSULIN PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL TUBED INSULIN PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL TUBELESS INSULIN PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL TUBELESS INSULIN PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL TUBELESS INSULIN PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MINIATURE PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MINIATURE PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MINIATURE PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CONVENTIONAL INSULIN PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CONVENTIONAL INSULIN PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CONVENTIONAL INSULIN PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL INSULIN PUMPS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL HYBRID CLOSED-LOOP SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL HYBRID CLOSED-LOOP SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL HYBRID CLOSED-LOOP SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL AUTOMATED INSULIN DELIVERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL AUTOMATED INSULIN DELIVERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL AUTOMATED INSULIN DELIVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL INSULIN PUMPS MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL RAPID ACTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL RAPID ACTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL RAPID ACTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SHORT ACTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SHORT ACTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SHORT ACTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL INSULIN PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL TYPE 1 DIABETES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL TYPE 1 DIABETES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL TYPE 1 DIABETES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL TYPE 2 DIABETES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL TYPE 2 DIABETES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL TYPE 2 DIABETES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL HOSPITAL PHARMACY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL HOSPITAL PHARMACY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL HOSPITAL PHARMACY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ONLINE PHARMACY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ONLINE PHARMACY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ONLINE PHARMACY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL RETAIL PHARMACY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL RETAIL PHARMACY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL RETAIL PHARMACY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL INSULIN PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC INSULIN PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC INSULIN PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC INSULIN PUMPS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC INSULIN PUMPS MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC INSULIN PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 56. NORTH AMERICA INSULIN PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 57. NORTH AMERICA INSULIN PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 58. NORTH AMERICA INSULIN PUMPS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 59. NORTH AMERICA INSULIN PUMPS MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 60. NORTH AMERICA INSULIN PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 61. NORTH AMERICA INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 62. LATIN AMERICA INSULIN PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 63. LATIN AMERICA INSULIN PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 64. LATIN AMERICA INSULIN PUMPS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 65. LATIN AMERICA INSULIN PUMPS MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 66. LATIN AMERICA INSULIN PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 67. LATIN AMERICA INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 68. EUROPE INSULIN PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 69. EUROPE INSULIN PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 70. EUROPE INSULIN PUMPS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 71. EUROPE INSULIN PUMPS MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE INSULIN PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 74. MIDDLE EAST INSULIN PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 75. MIDDLE EAST INSULIN PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. MIDDLE EAST INSULIN PUMPS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 77. MIDDLE EAST INSULIN PUMPS MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. MIDDLE EAST INSULIN PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 79. MIDDLE EAST INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 80. AFRICA INSULIN PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 81. AFRICA INSULIN PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 82. AFRICA INSULIN PUMPS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 83. AFRICA INSULIN PUMPS MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. AFRICA INSULIN PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 85. AFRICA INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL INSULIN PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. ASEAN INSULIN PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 88. ASEAN INSULIN PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. ASEAN INSULIN PUMPS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 90. ASEAN INSULIN PUMPS MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. ASEAN INSULIN PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 92. ASEAN INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 93. GCC INSULIN PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 94. GCC INSULIN PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. GCC INSULIN PUMPS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 96. GCC INSULIN PUMPS MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. GCC INSULIN PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 98. GCC INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPEAN UNION INSULIN PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPEAN UNION INSULIN PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPEAN UNION INSULIN PUMPS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPEAN UNION INSULIN PUMPS MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPEAN UNION INSULIN PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPEAN UNION INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 105. BRICS INSULIN PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 106. BRICS INSULIN PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. BRICS INSULIN PUMPS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 108. BRICS INSULIN PUMPS MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. BRICS INSULIN PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 110. BRICS INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 111. G7 INSULIN PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 112. G7 INSULIN PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. G7 INSULIN PUMPS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 114. G7 INSULIN PUMPS MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. G7 INSULIN PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. G7 INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 117. NATO INSULIN PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 118. NATO INSULIN PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. NATO INSULIN PUMPS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 120. NATO INSULIN PUMPS MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. NATO INSULIN PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. NATO INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL INSULIN PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. UNITED STATES INSULIN PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 125. UNITED STATES INSULIN PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. UNITED STATES INSULIN PUMPS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 127. UNITED STATES INSULIN PUMPS MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. UNITED STATES INSULIN PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. UNITED STATES INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 130. CANADA INSULIN PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 131. CANADA INSULIN PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. CANADA INSULIN PUMPS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 133. CANADA INSULIN PUMPS MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. CANADA INSULIN PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 135. CANADA INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 136. MEXICO INSULIN PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 137. MEXICO INSULIN PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. MEXICO INSULIN PUMPS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 139. MEXICO INSULIN PUMPS MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. MEXICO INSULIN PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. MEXICO INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 142. BRAZIL INSULIN PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 143. BRAZIL INSULIN PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. BRAZIL INSULIN PUMPS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 145. BRAZIL INSULIN PUMPS MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. BRAZIL INSULIN PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 147. BRAZIL INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 148. UNITED KINGDOM INSULIN PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 149. UNITED KINGDOM INSULIN PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. UNITED KINGDOM INSULIN PUMPS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 151. UNITED KINGDOM INSULIN PUMPS MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. UNITED KINGDOM INSULIN PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. UNITED KINGDOM INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 154. GERMANY INSULIN PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 155. GERMANY INSULIN PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. GERMANY INSULIN PUMPS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 157. GERMANY INSULIN PUMPS MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. GERMANY INSULIN PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. GERMANY INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 160. FRANCE INSULIN PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 161. FRANCE INSULIN PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. FRANCE INSULIN PUMPS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 163. FRANCE INSULIN PUMPS MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. FRANCE INSULIN PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 165. FRANCE INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 166. RUSSIA INSULIN PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 167. RUSSIA INSULIN PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. RUSSIA INSULIN PUMPS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 169. RUSSIA INSULIN PUMPS MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. RUSSIA INSULIN PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 171. RUSSIA INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 172. ITALY INSULIN PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 173. ITALY INSULIN PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. ITALY INSULIN PUMPS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 175. ITALY INSULIN PUMPS MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. ITALY INSULIN PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. ITALY INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 178. SPAIN INSULIN PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 179. SPAIN INSULIN PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. SPAIN INSULIN PUMPS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 181. SPAIN INSULIN PUMPS MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. SPAIN INSULIN PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 183. SPAIN INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 184. CHINA INSULIN PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 185. CHINA INSULIN PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. CHINA INSULIN PUMPS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 187. CHINA INSULIN PUMPS MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. CHINA INSULIN PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 189. CHINA INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 190. INDIA INSULIN PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 191. INDIA INSULIN PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. INDIA INSULIN PUMPS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 193. INDIA INSULIN PUMPS MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. INDIA INSULIN PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. INDIA INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 196. JAPAN INSULIN PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 197. JAPAN INSULIN PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. JAPAN INSULIN PUMPS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 199. JAPAN INSULIN PUMPS MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. JAPAN INSULIN PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 201. JAPAN INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 202. AUSTRALIA INSULIN PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 203. AUSTRALIA INSULIN PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. AUSTRALIA INSULIN PUMPS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 205. AUSTRALIA INSULIN PUMPS MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. AUSTRALIA INSULIN PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 207. AUSTRALIA INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 208. SOUTH KOREA INSULIN PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 209. SOUTH KOREA INSULIN PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. SOUTH KOREA INSULIN PUMPS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 211. SOUTH KOREA INSULIN PUMPS MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. SOUTH KOREA INSULIN PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 213. SOUTH KOREA INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)